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from 132 SLE patients were analyzed. The infection was found
in 30 SLE patients. The mean disease activity score in infected
group was higher than the score in non-infected group.
(p < 0.001) Stress and non-compliance were signiﬁcant positively
associated with more disease activity (r = +0.242, r = +0.276,
p = 0.005, 0.001 respectively). Disease duration, SLE knowledge
and self-management were non-statistically signiﬁcant with
disease activity. Infection, stress and compliance were predicted
factors in disease activity model. CONCLUSIONS: Factors asso-
ciated with SLE disease activity were infection, stress and
non-compliance.
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OBJECTIVES: To contrast the factors that are associated with
metabolic syndrome risk for US adolescents overall and US His-
panic adolescents. METHODS: At risk is deﬁned as having three
or more of the following: elevated fasting glucose, elevated SBP,
elevated DBP, elevated triglycerides, elevated BMI, elevated waist
circumference, or low HDL. Logistic regression and NHANES
2003–2006 data were used to examine the impact on metabolic
syndrome risks; gender, race, ethnicity, immigrant status, income,
insurance, parental education, activity levels, number of school
lunches and breakfasts per week, milk consumption, language
preference, and number of meals outside the home per week. US
adolescents overall were compared with US Hispanic adoles-
cents. Weighted sample sizes for Hispanic adolescents and US
born adolescents were 8,178,714, and 50,837,204 respectively.
At risk is deﬁned as having three or more of the following:
elevated fasting glucose, elevated SBP, elevated DBP, elevated
triglycerides, elevated BMI, elevated waist circumference, or low
HDL. Logistic regression and NHANES 2003–2006 data were
used to examine the impact on metabolic syndrome risks; gender,
race, ethnicity, immigrant status, income, insurance, parental
education, activity levels, number of school lunches and break-
fasts per week, milk consumption, language preference, and
number of meals outside the home per week. US adolescents
overall were compared with US Hispanic adolescents. Weighted
sample sizes for Hispanic adolescents and US born adolescents
were 8,178,714, and 50,837,204 respectively. RESULTS: The
results of the regressions were vastly different between US ado-
lescents and US Hispanic (First Generation and Native) adoles-
cents. All variables in the models were statistically signiﬁcant.
Where US adolescent females faced a lower risk (42%) of having
metabolic syndrome, US Hispanic females faced a higher risk
(17%). Notably, for those Hispanics that were ﬁrst generation,
risk increased by 65%. For US adolescents overall, low or middle
income levels increased risk three times, while low and middle
income level US Hispanic adolescents had a risk decrease of 77%
and 69% respectively. For every meal eaten outside the home per
week (excluding school meals) metabolic syndrome risk increases
for US adolescents by 4% and by 13% for Hispanic US adoles-
cents. CONCLUSIONS: Adolescents with metabolic syndrome
are at risk for acute cardiovascular endpoints, higher medical
utilization and expenditure, and lower quality of life. Interven-
tions should focus on education regarding healthy eating outside
the home despite limited ﬁnancial resources. A surprising result
of this analysis is the high price of acculturation for Hispanic ﬁrst
generation adolescents.
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OBJECTIVES: To examine the 5-year economic consequences
of reimbursing laparoscopic adjustable gastric banding (LAGB)
in addition to laparoscopic gastric bypass (LGBY) for a large
US managed care organization. METHODS: We used a Markov
model to estimate surgical costs and outcomes, weight loss, and
obesity-related costs and outcomes for LAGB, LGBY and no
treatment over a 5-year period for a hypothetical 1-million-
member managed care plan. Weight loss was estimated from a
randomized clinical trial (LAGB causes somewhat less weight
loss than LGBY). Complication rates, treatment and adverse
event costs, and medical costs were estimated from published and
publicly-available sources (LAGB has less severe complications
than LGBY). The treatment-eligible population was estimated
from US obesity rates, treatment guidelines, and clinical experi-
ence. Market expansion and substitution between LAGB and
LGBY were projected from historical trends and physician/
patient surveys. Budgetary impact, measured in 2007 dollars,
was calculated as net cost with LAGB versus without LAGB;
deterministic sensitivity analyses identiﬁed model drivers.
RESULTS: Mean 5-year cost for LAGB was less than LGBY at
$41,800 versus $52,800 per surgically-treated patient, primarily
due to lower surgical and complication costs. The net budgetary
impact was 14.5 M over 5 years ($1.8 M in year 1, rising to
$3.6 M in year 5). Net 5-year costs associated with market
expansion totaled $47.9 M, while patients receiving LAGB
instead of LGBY saw net cost-savings totaling $33.4 M. Results
are sensitive to estimates of the proportion of patients that would
choose LGBY in the absence of the LAGB option (net budgetary
impact: +$32.8 M to -$5.2 M) and estimates of market expan-
sion (net budgetary impact: $12.3 M to $16.6 M). CONCLU-
SIONS: For a hypothetical 1-million-member managed-care
organization, the estimated 5-year budgetary impact of reimburs-
ing LAGB is approximately $14.5 M. Although plan expendi-
tures increase as additional patients seek surgical treatment,
substantial savings are realized for patients receiving LAGB
instead of LGBY.
PSY8
BUDGET IMPACT ANALYSIS OF DEFERASIROX FORTHE
TREATMENT OF CHRONIC IRON OVERLOAD IN PATIENTS
WITH BETATHALASSAEMIA INVENETO REGION, ITALY
Venturini F,Adami S,Alberti C, Scroccaro G
Veneto Regional Drug Information Center,Verona, Italy
OBJECTIVES: This study aims to estimate the budget impact of
deferasirox (a once-daily oral iron chelator recently marketed in
Italy) in patients with beta-thalassaemia major and chronic iron
overload from blood transfusions, who live in the Veneto region.
Our analysis compares the costs of deferasirox versus deferox-
amine (which is the current standard of care for these patients)
and versus deferiprone, another oral iron chelator that is
licensed only for the treatment of iron-overloaded thalassaemic
patients, when deferoxamine is contraindicated or inadequate.
METHODS: Our analyses was conducted from the perspective
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